MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 113 filers reported holding MERSANA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,161 | -87.4% | 60,757 | -67.4% | 0.00% | -75.0% |
| Q2 2023 | $613,248 | -52.0% | 186,398 | -40.1% | 0.00% | -50.0% |
| Q1 2023 | $1,277,968 | -48.9% | 310,941 | -27.2% | 0.01% | -46.7% |
| Q4 2022 | $2,503,111 | -5.6% | 427,152 | +8.8% | 0.02% | 0.0% |
| Q3 2022 | $2,653,000 | +380.6% | 392,528 | +228.4% | 0.02% | +400.0% |
| Q2 2022 | $552,000 | -51.6% | 119,516 | -58.2% | 0.00% | -70.0% |
| Q1 2022 | $1,141,000 | +63.2% | 285,994 | +154.6% | 0.01% | +42.9% |
| Q4 2021 | $699,000 | +154.2% | 112,312 | +455.2% | 0.01% | +133.3% |
| Q2 2021 | $275,000 | +189.5% | 20,228 | +244.1% | 0.00% | +200.0% |
| Q1 2021 | $95,000 | -6.9% | 5,878 | +53.6% | 0.00% | 0.0% |
| Q4 2020 | $102,000 | -84.0% | 3,828 | -88.8% | 0.00% | -88.9% |
| Q3 2020 | $639,000 | -38.6% | 34,325 | -22.8% | 0.01% | -50.0% |
| Q2 2020 | $1,041,000 | +1185.2% | 44,485 | +220.0% | 0.02% | +800.0% |
| Q1 2020 | $81,000 | +523.1% | 13,900 | +526.1% | 0.00% | – |
| Q4 2019 | $13,000 | +85.7% | 2,220 | -48.9% | 0.00% | – |
| Q3 2019 | $7,000 | -88.5% | 4,347 | -71.2% | 0.00% | -100.0% |
| Q2 2019 | $61,000 | -18.7% | 15,083 | +5.9% | 0.00% | -50.0% |
| Q1 2019 | $75,000 | +257.1% | 14,248 | +172.5% | 0.00% | +100.0% |
| Q4 2018 | $21,000 | -27.6% | 5,228 | +223.5% | 0.00% | 0.0% |
| Q2 2018 | $29,000 | – | 1,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |